February 25, 2016

Money Will Help Bioscience Institute Address Metabolic Disease

Money Will Help Bioscience Institute Address Metabolic Disease

INDIANAPOLIS - The Indiana Biosciences Research Institute announced today a gift of $100 million in grants to grow Indiana’s bioscience sector.  The money aims to address metabolic disease – like obesity, high blood pressure and diabetes.

The Lilly Endowment and Eli Lilly and Company Foundation are donating the money that includes matching grants to the nonprofit Indiana Biosciences Research Institute in Indianapolis. This grant brings IBRI halfway to its $350 million goal.

IBRI aims to build a new building, hire more than 100 top researchers and advance the life science industry in Indiana.

About half a million Hoosiers have diabetes, 65 percent of Indiana’s adults are overweight and over a third have high blood pressure.

IBRI President and CEO, David Broecker says the institute aims to improve research internationally and fight a growing epidemic in Indiana.

"Unfortunately we’re at the bottom of the table when it comes to diabetes rates, obesity rates and high blood pressure," Broecker said.

IBRI was founded in 2013 to focus on metabolic disease and poor nutrition.  They hope to break ground on their new building later this year.
 

Support independent journalism today. You rely on WFYI to stay informed, and we depend on you to make our work possible. Donate to power our nonprofit reporting today. Give now.

 

 

Related News

Parks Are Essential For Quality Of Life. But What If A Community Park Doesn’t Serve Its People?
Updates On COVID-19 In Indiana: 3,255 Cases, 30 Deaths Added To State's Totals
IU Health Reports 125 Employees Leave After Refusing To Get COVID-19 Vaccine